These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2746044)

  • 1. Tissue and serum TPA in subjects at risk for bladder cancer.
    Giovagnoli MR; Di Fraia P; Manna A; Marafini V; Valli C; Marchei P; Vecchione A
    Int J Biol Markers; 1989; 4(1):13-7. PubMed ID: 2746044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue polypeptide antigen in the follow-up of patients with urinary bladder cancer compared with conventional urine cytology.
    Bantis A; Zissimopoulos A; Sountoulides P; Giannakopoulos S; Kalaitzis C; Athanassiadou P; Agelonidou E; Touloupidis S
    Hell J Nucl Med; 2010; 13(3):213-7. PubMed ID: 21193872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of urinary TPA in bladder cancer].
    Akagi T
    Nihon Hinyokika Gakkai Zasshi; 1988 Aug; 79(8):1337-47. PubMed ID: 3246818
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients.
    Kumar S; Costello CB; Glashan RW; Björklund B
    Br J Urol; 1981 Dec; 53(6):578-81. PubMed ID: 7317745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of tissue polypeptide antigen in the follow-up of bladder cancer.
    Menéndez López V; Galán JA; Fernández-Suárez A; López-Celada S; Alcover J; Filella X
    Urology; 2003 Aug; 62(2):243-8. PubMed ID: 12893327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum TPS versus TPA in Egyptian bladder cancer patients.
    Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P
    Int J Biol Markers; 1993; 8(4):221-6. PubMed ID: 7511149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of urinary CEA, ferritin and TPA in Egyptian bladder cancer patients.
    Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P
    Int J Biol Markers; 1992; 7(4):234-9. PubMed ID: 1491179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratins as serum markers in egyptian bladder cancer. A comparison of CYFRA 21-1, TPA and TPS.
    Mady EA
    Int J Biol Markers; 2001; 16(2):130-5. PubMed ID: 11471896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.
    Carbin BE; Ekman P; Eneroth P; Nilsson B
    Urol Res; 1989; 17(5):269-72. PubMed ID: 2815427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. A prospective study.
    Maulard C; Toubert ME; Chretien Y; Delanian S; Dufour B; Housset M
    Cancer; 1994 Jan; 73(2):394-8. PubMed ID: 8293406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the levels of tissue polypeptide antigen and carcinoembryonic antigen in the blood of workers exposed to aromatic amines].
    Lutz W; Krajewska B
    Med Pr; 1992; 43(4):297-301. PubMed ID: 1453945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma].
    Tizzani A; Casetta G; Cavallini A; Piana P; Piantino P
    Minerva Urol Nefrol; 1990; 42(2):69-71. PubMed ID: 2392743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improvement of the determination of urinary tissue polypeptide antigen (TPA) and the clinical study in bladder cancer patients].
    Morimoto S; Yoshida M; Yasukawa S; Uekado Y; Yoshida T; Aoshi H; Ebisuno S; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1988 Dec; 79(12):1954-61. PubMed ID: 3230746
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue polypeptide antigen (TPA) in urinary bladder cancer cytology: a follow-up study.
    Senatore S; Zizzi L; Blasi C; Alfieri G; Saccani Jotti G; Gabrielli M; Luccarelli S
    Oncology; 1990; 47(1):37-42. PubMed ID: 2300382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.
    van der Gaast A; Kirkels WJ; Blijenberg BG; Splinter TA
    J Cancer Res Clin Oncol; 1992; 118(8):626-8. PubMed ID: 1517284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of biological tumor markers for early detection of neoplastic changes in the bladder of persons exposed to aromatic amines].
    Hanke J; Krajewska B; Lutz W
    Med Pr; 1989; 40(6):376-80. PubMed ID: 2698439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor markers (CEA, TPA and CA 19-9) in urine of bladder cancer patients.
    Tizzani A; Cassetta G; Cicigoi A; Piana P; Cerchier A; Pecchio F; Piantino P
    Int J Biol Markers; 1987; 2(2):121-4. PubMed ID: 3482861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tissue polypeptide antigen in bladder cancer as a tumor marker: a prospective study.
    Maulard-Durdux C; Toubert ME; Hennequin C; Housset M
    J Clin Oncol; 1997 Dec; 15(12):3446-50. PubMed ID: 9396396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent elevation of tissue polypeptide antigen in the sera of workers exposed to bladder carcinogens.
    Kumar S; Wilson P; Brenchley P; Taylor G; Björklund B; Eklund G
    Int J Cancer; 1978 Nov; 22(5):542-5. PubMed ID: 82541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPA prognostic value in superficial bladder cancer.
    Filella X; Menendez V; Molina R; Alcover J; Carretero P; Ballesta AM
    Anticancer Res; 1996; 16(4B):2173-5. PubMed ID: 8694539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.